EUVIMEDEUVIMED entdecken
Crossref

Three Cases of irAE-associated Neuromuscular Disorders Presenting with Dysphagia

Toshiya Kimura, Tomoyuki Haji

Practica Oto-Rhino-Laryngologica · 2026 · 119 (5) · 327-332

DOI: 10.5631/jibirin.119.327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Practica Oto-Rhino-Laryngologica, 2026. Verfasst von Toshiya Kimura und 1 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) have rapidly become established as standard treatment agents for various cancers, which has led to an increase in the incidence of immune-related adverse events (irAEs). Among these, dysphagia has been reported to occur in 30%–50% of patients with irAE-associated neuromuscular disorders, representing a significant clinical challenge in the field of otorhinolaryngology. We report three cases of irAE-associated neuromuscular disorders who presented with dysphagia at our institution. Case 1 was a 64-year-old woman with lung adenocarcinoma who had recieved 32 courses of cisplatin, pemetrexed, and pembrolizumab. She developed limb numbness, difficulty in raising her head, arrhythmia, dysphagia, ptosis, and ocular motor dysfunction, and was diagnosed as having Fisher syndrome as an irAE. Case 2 was a 74-year-old man with metastatic renal cell carcinoma who received lenvatinib and pembrolizumab following laparoscopic nephrectomy. He developed destructive thyroiditis, neck weakness, extraocular muscle palsy, ptosis, muscle weakness, lower limb pain, and dysphagia, and was diagnosed as having myositis and myasthenia gravis as irAEs. Case 3 was an 83-year-old man with gastric neuroendocrine carcinoma and peritoneal dissemination who had received two courses of S-1, oxaliplatin, and nivolumab. He presented with ptosis, bradycardia, decreased consciousness, and rapidly progressive swallowing difficulty, showing a severe clinical course, and was diagnosed as having myositis, myasthenia gravis, and myocarditis as irAEs. A literature review of 13 cases, including the present series, revealed that the causative agents in all the cases were ICIs targeting PD-1 or PD-L1. The median age was 74 years, with the onset of the irAEs occurring within two months of the start of treatment in all cases. Lung cancer was the most common primary malignancy (7 cases). The swallowing prognosis was closely correlated with the overall clinical condition, with poor outcomes observed in all cases developing myocarditis.

Zitieren

APA

Kimura, T., & Haji, T. (2026). Three Cases of irAE-associated Neuromuscular Disorders Presenting with Dysphagia. Practica Oto-Rhino-Laryngologica, 119(5), 327-332. https://doi.org/10.5631/jibirin.119.327

Vancouver

Kimura T, Haji T. Three Cases of irAE-associated Neuromuscular Disorders Presenting with Dysphagia. Practica Oto-Rhino-Laryngologica. 2026;119(5):327-332. doi:10.5631/jibirin.119.327

BibTeX
@article{Kimura2026,
  author = {Kimura, Toshiya and Haji, Tomoyuki},
  title = {Three Cases of irAE-associated Neuromuscular Disorders Presenting with Dysphagia},
  journal = {Practica Oto-Rhino-Laryngologica},
  year = {2026},
  volume = {119},
  number = {5},
  pages = {327--332},
  doi = {10.5631/jibirin.119.327}
}
Kostenlos starten →